Furthermore, it has been shown that just docetaxel, not mitoxantrone, induced CCL2 expression in a dose-dependent manner in LNCaP and LAPC4 prostate cancer cell lines [33]. This evidence concerns the gene CCL2 and Familial prostate cancer.